Product Code: ETC8853056 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The tardive dyskinesia market in the Philippines is driven by the rising use of antipsychotic medications for mental health conditions such as schizophrenia and bipolar disorder. The demand for effective treatment options is increasing as awareness of the disorder improves among both patients and healthcare professionals. Pharmaceutical companies are investing in new drugs with fewer side effects and improved efficacy.
Tardive dyskinesia (TD), a side effect of long-term antipsychotic use, is an emerging concern in psychiatric treatment in the Philippines. The market for TD therapies is gradually expanding with the introduction of VMAT2 inhibitors and growing psychiatric awareness. However, underdiagnosis and limited access to specialty drugs remain key challenges.
The major hurdles include the underdiagnosis of tardive dyskinesia and limited awareness among patients and practitioners. High treatment costs, reliance on imported drugs, and minimal local research further complicate market development.
Tardive dyskinesia, often a side effect of long-term antipsychotic use, is gaining recognition among healthcare professionals. Opportunities exist in expanding diagnostic capabilities, increasing awareness, and introducing innovative treatment options. Pharmaceutical companies with CNS portfolios may find this market attractive for launching or distributing niche therapeutics.
Government policies support the pharmaceutical treatment of neurological disorders like tardive dyskinesia through universal healthcare coverage (PhilHealth) and access to essential medicines. The DOH works to expand availability of neurological care in public hospitals, and the FDA monitors the approval of new drugs targeting this condition.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Tardive Dyskinesia Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Tardive Dyskinesia Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Tardive Dyskinesia Market - Industry Life Cycle |
3.4 Philippines Tardive Dyskinesia Market - Porter's Five Forces |
3.5 Philippines Tardive Dyskinesia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Tardive Dyskinesia Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Tardive Dyskinesia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Tardive Dyskinesia Market Trends |
6 Philippines Tardive Dyskinesia Market, By Types |
6.1 Philippines Tardive Dyskinesia Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Tardive Dyskinesia Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Tardive Dyskinesia Market Revenues & Volume, By Valbenazine, 2021- 2031F |
6.1.4 Philippines Tardive Dyskinesia Market Revenues & Volume, By Amantadine, 2021- 2031F |
6.1.5 Philippines Tardive Dyskinesia Market Revenues & Volume, By Tetrabenazine, 2021- 2031F |
6.1.6 Philippines Tardive Dyskinesia Market Revenues & Volume, By Clonazepam, 2021- 2031F |
6.1.7 Philippines Tardive Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Tardive Dyskinesia Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Tardive Dyskinesia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Philippines Tardive Dyskinesia Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Philippines Tardive Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Tardive Dyskinesia Market Import-Export Trade Statistics |
7.1 Philippines Tardive Dyskinesia Market Export to Major Countries |
7.2 Philippines Tardive Dyskinesia Market Imports from Major Countries |
8 Philippines Tardive Dyskinesia Market Key Performance Indicators |
9 Philippines Tardive Dyskinesia Market - Opportunity Assessment |
9.1 Philippines Tardive Dyskinesia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Tardive Dyskinesia Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Tardive Dyskinesia Market - Competitive Landscape |
10.1 Philippines Tardive Dyskinesia Market Revenue Share, By Companies, 2024 |
10.2 Philippines Tardive Dyskinesia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |